🚀 Auro Pharma Jumps 4.25% Even as NIFTY Pharma Extends Losses

delivered a strong performance today, with its stock price surging up to 4.25% to touch a fresh 52-week high of 1359.90. Despite some profit booking, the stock managed to close with a solid gain of 2.7%, reflecting sustained investor interest and positive momentum. Notably, this upward movement came on a day when the NIFTY Pharma index declined by around 1%, marking its third consecutive session of losses. The contrast highlights Auro Pharma’s relative outperformance within the sector, suggesting stock-specific strength even as broader pharmaceutical stocks remained under pressure in today’s trading session. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.